Ligand validation:6RQ9

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RQ9_MES_A_401	18%	1%	0.271	0.856	2.1	5.6	1	9	0	0	100%	1
7NQM_MES_A_403	53%	10%	0.149	0.91	2.17	2.12	1	5	0	0	100%	0.61
5IBE_MES_A_408	51%	11%	0.164	0.92	2.28	1.89	1	5	0	0	100%	0.79
7NQN_MES_A_404	50%	3%	0.172	0.921	2.47	3.54	2	7	0	0	100%	0.62
7NQO_MES_A_403	42%	13%	0.136	0.855	1.87	2.12	1	2	2	0	100%	0.7
6RQ3_MES_A_408	36%	16%	0.204	0.898	1.93	1.75	1	3	0	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.